Lantern Pharma Inc. (LTRN)
Nasdaq • LTRN • US51654W1018
ORTEX Data Highlights
ORTEX Data Highlights
As of Oct 27, 2026, ORTEX estimated 5.3% of free float sold short, 1.8 days to cover, cost to borrow 3.38%. Sign up for live short interest data.
Market Cap
5.92m USD | # 11791 in US
Volume
241.67k shares | 329.07k USD
Shares Outstanding
12.78m
Free Float Shares
83.63% | 10.69m
